Home/Filings/4/0001193125-25-242567
4//SEC Filing

Pelish Henry E. 4

Accession 0001193125-25-242567

CIK 0001861560other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:31 PM ET

Size

16.4 KB

Accession

0001193125-25-242567

Insider Transaction Report

Form 4
Period: 2025-10-15
Pelish Henry E.
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2025-10-15$27.85/sh+7,495$208,73677,126 total
  • Exercise/Conversion

    Class A Common Stock

    2025-10-15$72.35/sh+3,042$220,08980,168 total
  • Sale

    Class A Common Stock

    2025-10-15$90.04/sh14,205$1,279,01865,963 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-10-153,04224,058 total
    Exercise: $72.35Exp: 2034-01-05Class A Common Stock (3,042 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-10-157,49513,156 total
    Exercise: $27.85Exp: 2033-01-06Class A Common Stock (7,495 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-10-15$18.93/sh+3,668$69,43569,631 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-10-153,66810,569 total
    Exercise: $18.93Exp: 2032-01-04Class A Common Stock (3,668 underlying)
Footnotes (5)
  • [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2024.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.84 to $90.23, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
  • [F3]The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
  • [F4]The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
  • [F5]The shares underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Documents

1 file

Issuer

Nuvalent, Inc.

CIK 0001861560

Entity typeother

Related Parties

1
  • filerCIK 0002029477

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:31 PM ET
Size
16.4 KB